Considerations when evaluating real-world data quality in the context of fitness for purpose

doi:10.1002/pds.5010

. 2020 Oct;29(10):1316-1318.

doi: 10.1002/pds.5010. Epub 2020 May 6.

Considerations when evaluating real-world data quality in the context of fitness for purpose

Matthew W Reynolds¹, Alison Bourke², Nancy A Dreyer³

Affiliations

¹ Real World Solutions, IQVIA, Maryland, USA.
² Real World Solutions, IQVIA United Kingdom, UK.
³ Real World Solutions, IQVIA, Massachusetts, USA.

PMID: 32374042
PMCID: PMC7687257
DOI: 10.1002/pds.5010

Considerations when evaluating real-world data quality in the context of fitness for purpose

Matthew W Reynolds et al. Pharmacoepidemiol Drug Saf. 2020 Oct.

. 2020 Oct;29(10):1316-1318.

doi: 10.1002/pds.5010. Epub 2020 May 6.

Authors

Matthew W Reynolds¹, Alison Bourke², Nancy A Dreyer³

Affiliations

¹ Real World Solutions, IQVIA, Maryland, USA.
² Real World Solutions, IQVIA United Kingdom, UK.
³ Real World Solutions, IQVIA, Massachusetts, USA.

PMID: 32374042
PMCID: PMC7687257
DOI: 10.1002/pds.5010

No abstract available

PubMed Disclaimer

Conflict of interest statement

The author(s) have no conflicts of interest to declare.

Cited by

Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large-scale COVID-19 surveillance system.
Mack CD, Wasserman EB, Hostler CJ, Solomon G, Anderson DJ, Walton P, Hawaldar K, Myers E, Best M, Eichner D, Mayer T, Sills A. Mack CD, et al. Pharmacoepidemiol Drug Saf. 2022 May;31(5):511-518. doi: 10.1002/pds.5424. Epub 2022 Mar 11. Pharmacoepidemiol Drug Saf. 2022. PMID: 35225407 Free PMC article.
Mind the clinical-analytic gap: Electronic health records and COVID-19 pandemic response.
Sudat SEK, Robinson SC, Mudiganti S, Mani A, Pressman AR. Sudat SEK, et al. J Biomed Inform. 2021 Apr;116:103715. doi: 10.1016/j.jbi.2021.103715. Epub 2021 Feb 19. J Biomed Inform. 2021. PMID: 33610878 Free PMC article.
Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium.
Kamdje Wabo G, Moorthy P, Siegel F, Seuchter SA, Ganslandt T. Kamdje Wabo G, et al. JMIR Med Inform. 2024 Aug 19;12:e57153. doi: 10.2196/57153. JMIR Med Inform. 2024. PMID: 39158950 Free PMC article.
RWD-Cockpit: Application for Quality Assessment of Real-world Data.
Babrak LM, Smakaj E, Agac T, Asprion PM, Grimberg F, der Werf DV, van Ginkel EW, Tosoni DD, Clay I, Degen M, Brodbeck D, Natali EN, Schkommodau E, Miho E. Babrak LM, et al. JMIR Form Res. 2022 Oct 18;6(10):e29920. doi: 10.2196/29920. JMIR Form Res. 2022. PMID: 35266872 Free PMC article.
Real-World Data Quality Framework for Oncology Time to Treatment Discontinuation Use Case: Implementation and Evaluation Study.
Ru B, Sillah A, Desai K, Chandwani S, Yao L, Kothari S. Ru B, et al. JMIR Med Inform. 2024 Mar 6;12:e47744. doi: 10.2196/47744. JMIR Med Inform. 2024. PMID: 38446504 Free PMC article.

See all "Cited by" articles

References

1. Dreyer NA. Advancing a framework for regulatory use of real‐world evidence: when real is reliable. Ther Innov Regul Sci. 2018;52(3):362‐368. - PMC - PubMed
1. Girman CJ, Ritchey ME, Zhou W, Dreyer NA. Considerations in characterizing real‐world data relevance and quality for regulatory purposes: a commentary. Pharmacoepidemiol Drug Saf. 2019;28(4):439‐442. 10.1002/pds.4697. - DOI - PMC - PubMed
1. Bourke A, Bate A, Sauer BC, Brown JS, Hall GC. Evidence generation from healthcare databases: recommendations for managing change. Pharmacoepidemiol Drug Saf. 2016;25:749‐754. 10.1002/pds.4004. - DOI - PubMed
1. Sentinel . Standardization and querying of data quality metrics and characteristics for electronic health data. https://www.sentinelinitiative.org/sentinel/methods/standardization-and-.... 2018. Accessed December 23, 2019.
1. Duke‐Margolis Center for Health Policy . Determining real‐world data’s fitness for use and the role of reliability. https://healthpolicy.duke.edu/sites/default/files/u31/rwd_reliability.pdf. 2019. Accessed December 19, 2019.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Dreyer NA. Advancing a framework for regulatory use of real‐world evidence: when real is reliable. Ther Innov Regul Sci. 2018;52(3):362‐368. - PMC - PubMed

[2] Dreyer NA. Advancing a framework for regulatory use of real‐world evidence: when real is reliable. Ther Innov Regul Sci. 2018;52(3):362‐368. - PMC - PubMed

[3] Girman CJ, Ritchey ME, Zhou W, Dreyer NA. Considerations in characterizing real‐world data relevance and quality for regulatory purposes: a commentary. Pharmacoepidemiol Drug Saf. 2019;28(4):439‐442. 10.1002/pds.4697. - DOI - PMC - PubMed

[4] Girman CJ, Ritchey ME, Zhou W, Dreyer NA. Considerations in characterizing real‐world data relevance and quality for regulatory purposes: a commentary. Pharmacoepidemiol Drug Saf. 2019;28(4):439‐442. 10.1002/pds.4697. - DOI - PMC - PubMed

[5] Bourke A, Bate A, Sauer BC, Brown JS, Hall GC. Evidence generation from healthcare databases: recommendations for managing change. Pharmacoepidemiol Drug Saf. 2016;25:749‐754. 10.1002/pds.4004. - DOI - PubMed

[6] Bourke A, Bate A, Sauer BC, Brown JS, Hall GC. Evidence generation from healthcare databases: recommendations for managing change. Pharmacoepidemiol Drug Saf. 2016;25:749‐754. 10.1002/pds.4004. - DOI - PubMed

[7] Sentinel . Standardization and querying of data quality metrics and characteristics for electronic health data. https://www.sentinelinitiative.org/sentinel/methods/standardization-and-.... 2018. Accessed December 23, 2019.

[8] Sentinel . Standardization and querying of data quality metrics and characteristics for electronic health data. https://www.sentinelinitiative.org/sentinel/methods/standardization-and-.... 2018. Accessed December 23, 2019.

[9] Duke‐Margolis Center for Health Policy . Determining real‐world data’s fitness for use and the role of reliability. https://healthpolicy.duke.edu/sites/default/files/u31/rwd_reliability.pdf. 2019. Accessed December 19, 2019.

[10] Duke‐Margolis Center for Health Policy . Determining real‐world data’s fitness for use and the role of reliability. https://healthpolicy.duke.edu/sites/default/files/u31/rwd_reliability.pdf. 2019. Accessed December 19, 2019.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Considerations when evaluating real-world data quality in the context of fitness for purpose

Affiliations

Considerations when evaluating real-world data quality in the context of fitness for purpose

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources